Mednow Ownership
MDNWF Stock | USD 0.02 0.00 0.00% |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Mednow |
Mednow Pink Sheet Ownership Analysis
About 48.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.97. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Mednow Inc recorded a loss per share of 0.71. The entity had not issued any dividends in recent years. Mednow Inc., a healthcare company, develops and operates a proprietary web and mobile application to facilitate the sale and distribution of prescription medications and the delivery of virtual care, telemedicine services, and doctor home visits in Canada. The company was incorporated in 2018 and is headquartered in Vancouver, Canada. Mednow is traded on OTC Exchange in the United States.The quote for Mednow Inc is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Mednow Inc contact Amir RPh at 855-686-6300 or learn more at https://www.mednow.ca.Currently Active Assets on Macroaxis
Other Information on Investing in Mednow Pink Sheet
Mednow financial ratios help investors to determine whether Mednow Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Mednow with respect to the benefits of owning Mednow security.